Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

Cambridge-based CMR Surgical secures FDA approval for revolutionary portable surgical robot

by October 16, 2024
October 16, 2024
Cambridge-based CMR Surgical secures FDA approval for revolutionary portable surgical robot

CMR Surgical, a Cambridge-based medtech company, has achieved a major breakthrough after receiving marketing authorisation from the US Food and Drug Administration (FDA) for its portable Versius Surgical System.

This marks a significant step into the world’s largest healthcare market, enabling CMR to prepare for sales of the Versius system in the US, initially for gallbladder removal surgeries in adult patients aged 22 and above.

The Versius system, designed to replicate the movements of the human arm and enhance surgeon precision, is already the second-most widely used robotic surgical system globally, with more than 26,000 surgeries completed, including in the UK. This approval comes nearly a decade after CMR Surgical was founded in 2014.

CMR Surgical’s headquarters and manufacturing site remain in Cambridge, with backing from international investors, including the Japanese tech giant SoftBank and China’s Tencent. The company, which has raised approximately $1 billion since its inception, employs over 500 staff, 400 of whom are based in the UK. The company’s $600 million funding round in 2021, led by SoftBank, marked the largest-ever private investment in the global medtech sector.

Mark Slack, CMR’s chief medical officer and co-founder, highlighted the importance of the approval: “Securing FDA marketing authorisation for Versius is a significant milestone for CMR and, most importantly, for hospitals and patients who will now have greater access to robotic-assisted surgery.”

Beyond the US, CMR Surgical is also seeking regulatory approval in other major healthcare markets, including Japan and China.

Although the company had previously considered an initial public offering (IPO), no formal plans have been announced. An IPO remains an option for the future as CMR continues its expansion into key international markets.

Founded in 2014, CMR Surgical has grown rapidly, advancing the accessibility and efficiency of robotic-assisted surgery globally. Its Versius system now stands as a key competitor in the burgeoning market for medical robotics, with the latest FDA approval set to enhance its presence on the global stage.

Read more:
Cambridge-based CMR Surgical secures FDA approval for revolutionary portable surgical robot

0
FacebookTwitterGoogle +Pinterest
previous post
VP Harris to sit down hours from now with Bret Baier for first Fox News interview
next post
Premier Inn owner Whitbread to return £2bn to shareholders as it eyes profit growth and expansion

You may also like

m3ter raises $14M Series A to fuel further...

April 27, 2023

Apple halts Advanced Data Protection in the UK:...

February 26, 2025

Ads for two UK funeral firms banned over...

August 4, 2022

Selling CSGO Items- How Easy Is That?

January 20, 2025

Restaurants brace for Reeves’s £25bn tax raid as...

February 18, 2025

‘EV Health Checker’ creator ClearWatt reaches £200,000 fundraising...

May 22, 2024

UK battery start-up Britishvolt makes majority of 300...

January 17, 2023

MuchBetter Review: The Top Choice for Multilingual Payment...

April 6, 2023

POS Integration: How to Connect Offline and Online...

August 15, 2023

Two-thirds of UK’s top restaurants in the red...

August 8, 2022

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Trump warns of ‘serious consequences’ if Elon Musk funds Democrats

      June 7, 2025
    • Musk jokes about reconsidering stance on Big Beautiful Bill after Schiff’s praise

      June 7, 2025
    • Musk deletes explosive posts about Trump and Epstein files

      June 7, 2025
    • House witness flips script on Dem who ambushed him during hearing with unearthed tweet: ‘Iceberg is ahead’

      June 7, 2025
    • Call with China’s Xi, and Trump-Musk exchange fueled barbs during 20th week in office

      June 7, 2025
    • Trump’s conservative allies warn Congress faces critical ‘test’ with $9.4B spending cut proposal

      June 7, 2025

    Categories

    • Business (8,152)
    • Investing (2,019)
    • Politics (15,568)
    • Stocks (3,136)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved